Peters, L; Mocroft, A; Grint, D; Moreno, S; Calmy, A; Jevtovic, D; Sambatakou, H; Lacombe, K; De Wit, S; Rockstroh, J; +11 more... Smidt, J; Karpov, I; Grzeszczuk, A; Haziosmanovic, V; Gottfredsson, M; Radoi, R; Kuzovatova, E; Orkin, C; Ridolfo, AL; Zapirain, J; Lundgren, J; (2018) Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study. Antiviral therapy. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP3218 Full text not available from this repository.

Hankins, CA; Koulla-Shiro, S; Kilmarx, P; Ferrari, G; Schechter, M; Kane, CT; Venter, F; Boucher, CA; Ross, AL; Zewdie, D; +2 more... Eholié, SP; Katabira, E; (2017) Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon. Antiviral therapy, 22 (2). pp. 179-184. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP3165 Full text not available from this repository.

Hoppe, A; Giuliano, M; Lugemwa, A; Thompson, JA; Floridia, M; Walker, AS; Senoga, I; Abwola, MC; Pirillo, MF; Kityo, CM; +3 more... Arenas-Pinto, A; Paton, NI; Team, ET; (2017) HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa. Antiviral therapy. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP3200

Hoffmann, CJ; Ledwaba, J; Li, JF; Johnston, V; Hunt, G; Fielding, KL; Chaisson, RE; Churchyard, GJ; Grant, AD; Johnson, JA; +2 more... Charalambous, S; Morris, L; (2013) Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa. Antiviral therapy, 18 (7). pp. 915-20. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP2652

Worodria, W; Menten, J; Massinga-Loembe, M; Mazakpwe, D; Bagenda, D; Koole, O; Mayanja-Kizza, H; Kestens, L; Mugerwa, R; Reiss, P; +2 more... Colebunders, R; TB-IRIS Study Group; (2012) Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection. Antiviral therapy, 17 (5). pp. 841-8. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP2108 Full text not available from this repository.

Arenas-Pinto, A; Grant, A; Bhaskaran, K; Copas, A; Carr, A; Worm, SW; Martinez, E; Reiss, P; Dunn, D; Weber, R; +3 more... Hoy, J; Weller, I; Lactic Acidosis Int Study, G; (2011) Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis. Antiviral therapy, 16 (2). pp. 219-226. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP1732

Arenas-Pinto, A; Weller, I; Ekong, R; Grant, A; Karstaedt, A; Reiss, P; Telisinghe, L; Weber, R; Bolhaar, M; Bradman, N; +1 more... Ingram, C; (2011) Common inherited mitochondrial DNA mutations and nucleoside reverse transcriptase inhibitor-induced severe hyperlactataemia in HIV-infected adults: an exploratory study. Antiviral therapy, 17 (2). pp. 275-82. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP1947 Full text not available from this repository.

Pilger, D; Hauser, A; Simogy, S; Mugenyi, K; Kabasinguzi, R; Kuecherer, C; Harms, G; Kunz, A; (2011) Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis. Antiviral therapy, 16 (1). pp. 109-113. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP1698 Full text not available from this repository.

SMART Study Group including Fleck, Suzanne; Peters, L; Neuhaus, J; Mocroft, A; Soriano, V; Rockstroh, J; Dore, G; Puoti, M; Tedaldi, E; Clotet, B; +3 more... Kupfer, B; Lundgren, JD; Klein, MB; (2011) Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study. Antiviral therapy, 16 (5). pp. 667-75. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP1815 Full text not available from this repository.

Stöhr, W; Reid, A; Walker, AS; Ssali, F; Munderi, P; Mambule, I; Kityo, C; Grosskurth, H; Gilks, CF; Gibb, DM; +2 more... Hakim, J; DART Trial Team; (2011) Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa. Antiviral therapy, 16 (7). pp. 1011-20. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP1832 Full text not available from this repository.

Arenas-Pinto, A; Weller, I; Ekong, R; Grant, A; Karstaedt, A; Telisinghe, L; Bolhaar, M; Charalambous, S; Bradman, N; Ingram, C; (2010) Lack of association between mitochondrial DNA polymorphisms and didexoxynucleoside-induced hyperlactataemia in Black African HIV-1 infected patients. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/1144 Full text not available from this repository.

Chilton, DN; Castro, H; Lattimore, S; Harrison, LJ; Fearnhill, E; Delpech, V; Rice, B; Pillay, D; Dunn, DT; UK Collaborative Group on HIV Drug Resistance; +36 more... , COLLABORATORS; Anderson, J; Asboe, D; Pozniak, A; Burns, S; Cameron, S; Cane, P; Chrystie, I; Churchill, D; Clark, D; Delpech, V; Pillay, D; Lazarus, L; Dunn, D; Fearnhill, E; Castro, H; Porter, K; Easterbrook, P; Zuckerman, M; Geretti, AM; Kellam, P; Pillay, D; Phillips, A; Sabin, C; Goldberg, D; Gompels, M; Hale, A; Kaye, S; Konov, S; Leigh-Brown, A; Mackie, N; Orkin, C; Smit, E; Tilston, P; Williams, I; Zhang, H; (2010) HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom. Antiviral therapy, 15 (7). pp. 985-91. ISSN 1359-6535 DOI: https://doi.org/10.3851/IMP1658 Full text not available from this repository.

Ibrahim, F; Hamzah, L; Jones, R; Nitsch, D; Sabin, C; Post, F; (2010) Use of CKD-EPI and MDRD to estimate baseline renal function as predictor of mortality in HIV-infected patients. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/1156 Full text not available from this repository.

Cohen, K; Grant, A; Dandara, C; McIlleron, H; Pemba, L; Fielding, K; Charalombous, S; Churchyard, G; Smith, P; Maartens, G; (2009) Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa. Antiviral therapy, 14 (5). pp. 687-95. ISSN 1359-6535 https://researchonline.lshtm.ac.uk/id/eprint/4843 Full text not available from this repository.

Arenas-Pinto, A; Bhaskaran, K; Dunn, D; Weller, IV; (2008) The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial. Antiviral therapy, 13 (2). pp. 289-95. ISSN 1359-6535 https://researchonline.lshtm.ac.uk/id/eprint/7356 Full text not available from this repository.

Phillips, A; Pillay, D; Miners, A; Bennett, D; Gilks, CF; Lundgren, JD; (2008) Predicting the effects on resistance of lack of viral load monitoring in resource-limited settings. Antiviral therapy, 13 (4). A159-A159. ISSN 1359-6535 https://researchonline.lshtm.ac.uk/id/eprint/7104 Full text not available from this repository.

Stöhr, W; Walker, AS; Munderi, P; Tugume, S; Gilks, CF; Darbyshire, JH; Hakim, J; DART Trial, . [ inc Grosskurth, H; ]; (2008) Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae. Antiviral therapy, 13 (6). pp. 761-70. ISSN 1359-6535 https://researchonline.lshtm.ac.uk/id/eprint/125007 Full text not available from this repository.

Ellis, JC; L'homme, RF; Ewings, FM; Mulenga, V; Bell, F; Chileshe, R; Molyneux, E; Abernethy, J; van Oosterhout, JJ; Chintu, C; +3 more... Walker, AS; Gibb, DM; Burger, DM; (2007) Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia. Antiviral therapy, 12 (2). pp. 253-60. ISSN 1359-6535 https://researchonline.lshtm.ac.uk/id/eprint/427478 Full text not available from this repository.

Lee, KJ; Shingadia, D; Pillay, D; Walker, AS; Riordan, A; Menson, E; Duong, T; Tudor-Williams, G; Gibb, DM; (2007) Transient viral load increases in HIV-infected children in the UK and Ireland: what do they mean? Antiviral therapy, 12 (6). pp. 949-956. ISSN 1359-6535 https://researchonline.lshtm.ac.uk/id/eprint/8575 Full text not available from this repository.

Orrell, C; Harling, G; Lawn, SD; Kaplan, R; McNally, M; Bekker, LG; Wood, R; (2007) Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antiviral therapy, 12 (1). pp. 83-8. ISSN 1359-6535 https://researchonline.lshtm.ac.uk/id/eprint/9216 Full text not available from this repository.

Ssali, F; Stöhr, W; Munderi, P; Reid, A; Walker, AS; Gibb, DM; Mugyenyi, P; Kityo, C; Grosskurth, H; Hakim, J; +5 more... Byakwaga, H; Katabira, E; Darbyshire, JH; Gilks, CF; DART Trial Team; (2006) Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Antiviral therapy, 11 (6). pp. 741-9. ISSN 1359-6535 https://researchonline.lshtm.ac.uk/id/eprint/53703 Full text not available from this repository.

Evans, SJW; (2005) Drug safety in the balance: past, present and future. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/6435 Full text not available from this repository.

Njai, HF; Lewi, PJ; Janssen, CG; Garcia, S; Fransen, K; Kestens, L; Vanham, G; Janssen, PA; (2005) Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells. Antiviral therapy, 10 (2). pp. 255-62. ISSN 1359-6535 https://researchonline.lshtm.ac.uk/id/eprint/4217 Full text not available from this repository.

Arenas-Pinto, A; Grant, AD; Edwards, S; Weller, IVD; (2002) Lactic acidosis in HIV-infected patients: a systematic review of published cases. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/17353 Full text not available from this repository.